Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO29008 | Coptis teeta | Species | Ranunculaceae | Eukaryota | TM-MC* | |||
NPO14045 | Corydalis decumbens | Species | Papaveraceae | Eukaryota | TM-MC* | |||
NPO24476 | Phellodendron amurense | Species | Rutaceae | Eukaryota | TM-MC* | |||
NPO22242 | Phellodendron chinense | Species | Rutaceae | Eukaryota | TM-MC* | |||
NPO26538 | Phellodendron chinese | Species | Rutaceae | Eukaryota | TM-MC* | |||
NPO10715 | Fibraurea tinctoria | Species | Menispermaceae | Eukaryota |
PMID[17994701] |
|||
NPO5649 | Coptis chinensis | Species | Ranunculaceae | Eukaryota | TM-MC* | |||
NPO22622 | Coptis deltoidea | Species | Ranunculaceae | Eukaryota | TM-MC* | |||
NPO13757 | Coptis japonica | Species | Ranunculaceae | Eukaryota | TM-MC* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.281 | ug/ml | 3286870 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 0.163 | ug/ml | 3286870 |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | IC50 | = | 900 | nM | 17994701 |
NPT2 | Others | Unspecified | Inhibition | = | 19 | % | 19716293 | |
NPT2655 | Individual Protein | Cell division control protein 42 homolog | Homo sapiens | Inhibition | = | 8 | % | 19716293 |
NPT2656 | Individual Protein | Ras-related C3 botulinum toxin substrate 1 | Homo sapiens | Inhibition | = | 15 | % | 19716293 |
NPT1229 | Cell Line | Huh-7 | Homo sapiens | CC50 | > | 100000 | nM | 18579783 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | EC50 | = | 766 | nM | 18579783 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | EC50 | = | 697 | nM | 18579783 |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 28183.8 | nM | PubChem BioAssay data set |
NPT51 | Individual Protein | Microtubule-associated protein tau | Homo sapiens | Potency | = | 17782.8 | nM | PubChem BioAssay data set |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 7.9 | nM | PubChem BioAssay data set |
NPT55 | Individual Protein | Putative fructose-1,6-bisphosphate aldolase | Giardia intestinalis | Potency | = | 17740.7 | nM | PubChem BioAssay data set |
NPT56 | Individual Protein | Beta-lactamase AmpC | Escherichia coli K-12 | Potency | = | 5623.4 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT63 | Individual Protein | Bromodomain adjacent to zinc finger domain protein 2B | Homo sapiens | Potency | 707.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | GI50 | = | 57430 | nM | 21401114 | |
NPT2470 | Cell Line | G-402 | Homo sapiens | GI50 | = | 83140 | nM | 21401114 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 165.1 | nM | PubChem BioAssay data set | |
NPT803 | Individual Protein | Flap endonuclease 1 | Homo sapiens | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 185.3 | nM | PubChem BioAssay data set | |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT108 | Individual Protein | Estrogen receptor alpha | Homo sapiens | Activity | = | 46.89 | % | 22137340 |
NPT108 | Individual Protein | Estrogen receptor alpha | Homo sapiens | Activity | = | 64.78 | % | 22137340 |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 34833.73 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 52360.04 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 39902.49 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 27861.21 | nM | PubChem BioAssay data set | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 15452.54 | nM | PubChem BioAssay data set | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 97051 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 82413.81 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 83368.12 | nM | PubChem BioAssay data set | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 48528.85 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 100000 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 24434.31 | nM | PubChem BioAssay data set | |
NPT2658 | Individual Protein | Snake venom metalloproteinase Bap1 | Bothrops asper | IC50 | = | 93300 | nM | 24900507 |
NPT2 | Others | Unspecified | Potency | 11220.2 | nM | PubChem BioAssay data set | ||
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 7943.3 | nM | PubChem BioAssay data set | |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | 72.59 | % | 23062825 |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | 7.47 | % | 23062825 |
NPT822 | Organism | Lemna minor | Lemna minor | Activity | = | 0 | % | 11055412 |
NPT823 | Organism | Agrostis stolonifera var. palustris | Agrostis stolonifera var. palustris | Activity | = | 0 | % | 11055412 |
NPT824 | Organism | Ustilago maydis | Ustilago maydis | Inhibition | = | 0 | % | 11055412 |
NPT825 | Organism | Phytophthora infestans | Phytophthora infestans | Inhibition | = | 0 | % | 11055412 |
NPT529 | Organism | Rhizoctonia solani | Rhizoctonia solani | Inhibition | = | 0 | % | 11055412 |
NPT826 | Organism | Magnaporthe oryzae | Magnaporthe oryzae | Inhibition | = | 0 | % | 11055412 |
NPT827 | Organism | Mycosphaerella graminicola | Mycosphaerella graminicola | Inhibition | = | 80 | % | 11055412 |
NPT828 | Organism | Phaeosphaeria nodorum | Phaeosphaeria nodorum | Inhibition | = | 0 | % | 11055412 |
NPT829 | Organism | Puccinia recondita | Puccinia recondita | Activity | = | 0 | % | 11055412 |
NPT825 | Organism | Phytophthora infestans | Phytophthora infestans | Activity | = | 0 | % | 11055412 |
NPT828 | Organism | Phaeosphaeria nodorum | Phaeosphaeria nodorum | Activity | = | 0 | % | 11055412 |
NPT830 | Organism | Blumeria graminis f. sp. tritici | Blumeria graminis f. sp. tritici | Activity | = | 0 | % | 11055412 |
NPT2 | Others | Unspecified | Potency | 5173.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3264.3 | nM | PubChem BioAssay data set | ||
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 3981.1 | nM | PubChem BioAssay data set | |
NPT1274 | Individual Protein | DNA repair protein RAD52 homolog | Homo sapiens | AC50 | = | 5190 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | 6513.1 | nM | PubChem BioAssay data set | ||
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 110.13 | % | 23571415 |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 97.62 | % | 23571415 |
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC36229 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC16452 |
1.0 | High Similarity | NPC476581 |
0.9834 | High Similarity | NPC31930 |
0.9724 | High Similarity | NPC476578 |
0.9724 | High Similarity | NPC4071 |
0.9724 | High Similarity | NPC476582 |
0.9628 | High Similarity | NPC112206 |
0.9628 | High Similarity | NPC296482 |
0.9628 | High Similarity | NPC202768 |
0.9628 | High Similarity | NPC202605 |
0.9628 | High Similarity | NPC53069 |
0.9421 | High Similarity | NPC96405 |
0.9421 | High Similarity | NPC171409 |
0.9392 | High Similarity | NPC195268 |
0.9392 | High Similarity | NPC133140 |
0.9362 | High Similarity | NPC313189 |
0.9158 | High Similarity | NPC135549 |
0.9115 | High Similarity | NPC290689 |
0.9043 | High Similarity | NPC477019 |
0.8889 | High Similarity | NPC23614 |
0.8889 | High Similarity | NPC100079 |
0.8842 | High Similarity | NPC234197 |
0.875 | High Similarity | NPC46451 |
0.8737 | High Similarity | NPC235076 |
0.8731 | High Similarity | NPC251160 |
0.8687 | High Similarity | NPC149471 |
0.8687 | High Similarity | NPC271215 |
0.8607 | High Similarity | NPC473822 |
0.8599 | High Similarity | NPC201508 |
0.8535 | High Similarity | NPC188420 |
0.8522 | High Similarity | NPC174049 |
0.85 | High Similarity | NPC236668 |
0.8458 | Intermediate Similarity | NPC146976 |
0.8439 | Intermediate Similarity | NPC122463 |
0.8439 | Intermediate Similarity | NPC118121 |
0.8429 | Intermediate Similarity | NPC96584 |
0.8429 | Intermediate Similarity | NPC255800 |
0.8415 | Intermediate Similarity | NPC312872 |
0.8402 | Intermediate Similarity | NPC287437 |
0.8284 | Intermediate Similarity | NPC473513 |
0.8261 | Intermediate Similarity | NPC210434 |
0.8244 | Intermediate Similarity | NPC204446 |
0.8241 | Intermediate Similarity | NPC470164 |
0.8241 | Intermediate Similarity | NPC323345 |
0.8227 | Intermediate Similarity | NPC162530 |
0.8211 | Intermediate Similarity | NPC204385 |
0.8199 | Intermediate Similarity | NPC24019 |
0.8178 | Intermediate Similarity | NPC295228 |
0.8155 | Intermediate Similarity | NPC173080 |
0.8137 | Intermediate Similarity | NPC266931 |
0.8112 | Intermediate Similarity | NPC224928 |
0.81 | Intermediate Similarity | NPC285558 |
0.8079 | Intermediate Similarity | NPC470020 |
0.8057 | Intermediate Similarity | NPC214980 |
0.8 | Intermediate Similarity | NPC22481 |
0.8 | Intermediate Similarity | NPC114335 |
0.8 | Intermediate Similarity | NPC280272 |
0.8 | Intermediate Similarity | NPC206201 |
0.8 | Intermediate Similarity | NPC141915 |
0.8 | Intermediate Similarity | NPC280964 |
0.799 | Intermediate Similarity | NPC167860 |
0.799 | Intermediate Similarity | NPC123976 |
0.7981 | Intermediate Similarity | NPC476997 |
0.7973 | Intermediate Similarity | NPC270515 |
0.7963 | Intermediate Similarity | NPC90875 |
0.7962 | Intermediate Similarity | NPC322482 |
0.7953 | Intermediate Similarity | NPC233334 |
0.7944 | Intermediate Similarity | NPC278525 |
0.7944 | Intermediate Similarity | NPC476998 |
0.7944 | Intermediate Similarity | NPC469792 |
0.7944 | Intermediate Similarity | NPC476996 |
0.7926 | Intermediate Similarity | NPC108342 |
0.7921 | Intermediate Similarity | NPC264166 |
0.7921 | Intermediate Similarity | NPC274291 |
0.7921 | Intermediate Similarity | NPC47059 |
0.7921 | Intermediate Similarity | NPC165349 |
0.7921 | Intermediate Similarity | NPC118832 |
0.7921 | Intermediate Similarity | NPC329708 |
0.7913 | Intermediate Similarity | NPC316981 |
0.7907 | Intermediate Similarity | NPC476999 |
0.7897 | Intermediate Similarity | NPC476994 |
0.789 | Intermediate Similarity | NPC189903 |
0.789 | Intermediate Similarity | NPC182907 |
0.788 | Intermediate Similarity | NPC253675 |
0.7864 | Intermediate Similarity | NPC119134 |
0.7864 | Intermediate Similarity | NPC208284 |
0.7857 | Intermediate Similarity | NPC193267 |
0.7857 | Intermediate Similarity | NPC213530 |
0.7854 | Intermediate Similarity | NPC166722 |
0.7854 | Intermediate Similarity | NPC174758 |
0.7854 | Intermediate Similarity | NPC174672 |
0.7814 | Intermediate Similarity | NPC26850 |
0.7811 | Intermediate Similarity | NPC11017 |
0.7805 | Intermediate Similarity | NPC82548 |
0.7794 | Intermediate Similarity | NPC472111 |
0.7784 | Intermediate Similarity | NPC177404 |
0.7783 | Intermediate Similarity | NPC475774 |
0.7772 | Intermediate Similarity | NPC232727 |
0.7767 | Intermediate Similarity | NPC469589 |
0.7766 | Intermediate Similarity | NPC92111 |
0.7731 | Intermediate Similarity | NPC246381 |
0.7723 | Intermediate Similarity | NPC176538 |
0.7723 | Intermediate Similarity | NPC315957 |
0.7718 | Intermediate Similarity | NPC470931 |
0.7716 | Intermediate Similarity | NPC76748 |
0.7714 | Intermediate Similarity | NPC170114 |
0.7713 | Intermediate Similarity | NPC15406 |
0.7703 | Intermediate Similarity | NPC210296 |
0.7696 | Intermediate Similarity | NPC469440 |
0.7688 | Intermediate Similarity | NPC329541 |
0.7688 | Intermediate Similarity | NPC307963 |
0.7679 | Intermediate Similarity | NPC124313 |
0.7668 | Intermediate Similarity | NPC84164 |
0.7668 | Intermediate Similarity | NPC207283 |
0.7667 | Intermediate Similarity | NPC470549 |
0.7665 | Intermediate Similarity | NPC296527 |
0.7659 | Intermediate Similarity | NPC137929 |
0.7659 | Intermediate Similarity | NPC164374 |
0.7656 | Intermediate Similarity | NPC285941 |
0.765 | Intermediate Similarity | NPC26872 |
0.7647 | Intermediate Similarity | NPC199277 |
0.7647 | Intermediate Similarity | NPC135887 |
0.7647 | Intermediate Similarity | NPC476995 |
0.7644 | Intermediate Similarity | NPC11464 |
0.7641 | Intermediate Similarity | NPC284559 |
0.7639 | Intermediate Similarity | NPC200888 |
0.763 | Intermediate Similarity | NPC274982 |
0.7629 | Intermediate Similarity | NPC470474 |
0.7623 | Intermediate Similarity | NPC217554 |
0.7621 | Intermediate Similarity | NPC304183 |
0.7612 | Intermediate Similarity | NPC473053 |
0.7612 | Intermediate Similarity | NPC251090 |
0.7612 | Intermediate Similarity | NPC13880 |
0.7606 | Intermediate Similarity | NPC471178 |
0.7606 | Intermediate Similarity | NPC17565 |
0.76 | Intermediate Similarity | NPC284141 |
0.7588 | Intermediate Similarity | NPC469390 |
0.7579 | Intermediate Similarity | NPC476518 |
0.7574 | Intermediate Similarity | NPC267928 |
0.7571 | Intermediate Similarity | NPC264176 |
0.7569 | Intermediate Similarity | NPC314954 |
0.7568 | Intermediate Similarity | NPC473183 |
0.7564 | Intermediate Similarity | NPC132385 |
0.7562 | Intermediate Similarity | NPC131017 |
0.7558 | Intermediate Similarity | NPC470018 |
0.7554 | Intermediate Similarity | NPC476568 |
0.7549 | Intermediate Similarity | NPC329747 |
0.7549 | Intermediate Similarity | NPC329793 |
0.7545 | Intermediate Similarity | NPC469554 |
0.7539 | Intermediate Similarity | NPC121658 |
0.7539 | Intermediate Similarity | NPC14651 |
0.7538 | Intermediate Similarity | NPC190461 |
0.7537 | Intermediate Similarity | NPC127085 |
0.7534 | Intermediate Similarity | NPC11408 |
0.7527 | Intermediate Similarity | NPC106295 |
0.7527 | Intermediate Similarity | NPC51957 |
0.7527 | Intermediate Similarity | NPC476144 |
0.7527 | Intermediate Similarity | NPC210437 |
0.7527 | Intermediate Similarity | NPC16107 |
0.7524 | Intermediate Similarity | NPC162484 |
0.7523 | Intermediate Similarity | NPC74575 |
0.7513 | Intermediate Similarity | NPC20249 |
0.7512 | Intermediate Similarity | NPC201697 |
0.7511 | Intermediate Similarity | NPC183537 |
0.75 | Intermediate Similarity | NPC193777 |
0.75 | Intermediate Similarity | NPC216816 |
0.7488 | Intermediate Similarity | NPC472098 |
0.7488 | Intermediate Similarity | NPC26679 |
0.7486 | Intermediate Similarity | NPC7467 |
0.7477 | Intermediate Similarity | NPC473184 |
0.7476 | Intermediate Similarity | NPC66815 |
0.7475 | Intermediate Similarity | NPC61350 |
0.7467 | Intermediate Similarity | NPC134637 |
0.7466 | Intermediate Similarity | NPC49547 |
0.7466 | Intermediate Similarity | NPC101543 |
0.7465 | Intermediate Similarity | NPC65277 |
0.7464 | Intermediate Similarity | NPC475910 |
0.7464 | Intermediate Similarity | NPC287208 |
0.7462 | Intermediate Similarity | NPC179704 |
0.7454 | Intermediate Similarity | NPC310118 |
0.7453 | Intermediate Similarity | NPC469592 |
0.7453 | Intermediate Similarity | NPC471080 |
0.7451 | Intermediate Similarity | NPC72211 |
0.7443 | Intermediate Similarity | NPC110151 |
0.7442 | Intermediate Similarity | NPC148409 |
0.744 | Intermediate Similarity | NPC476138 |
0.744 | Intermediate Similarity | NPC245816 |
0.7435 | Intermediate Similarity | NPC77878 |
0.7429 | Intermediate Similarity | NPC185782 |
0.7427 | Intermediate Similarity | NPC267423 |
0.7421 | Intermediate Similarity | NPC24954 |
0.7409 | Intermediate Similarity | NPC111624 |
0.7407 | Intermediate Similarity | NPC124542 |
0.7407 | Intermediate Similarity | NPC477533 |
0.7407 | Intermediate Similarity | NPC471177 |
0.7407 | Intermediate Similarity | NPC59779 |
0.7402 | Intermediate Similarity | NPC70956 |
0.7402 | Intermediate Similarity | NPC243834 |
0.74 | Intermediate Similarity | NPC477186 |
0.7395 | Intermediate Similarity | NPC469594 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC36229 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9628 | High Similarity | NPD3816 | Phase 1 |
0.9628 | High Similarity | NPD3815 | Phase 1 |
0.9392 | High Similarity | NPD3924 | Approved |
0.9392 | High Similarity | NPD3922 | Approved |
0.9392 | High Similarity | NPD3923 | Approved |
0.9392 | High Similarity | NPD3921 | Approved |
0.8785 | High Similarity | NPD3920 | Phase 2 |
0.875 | High Similarity | NPD3763 | Approved |
0.836 | Intermediate Similarity | NPD6257 | Clinical (unspecified phase) |
0.8333 | Intermediate Similarity | NPD6230 | Discontinued |
0.8281 | Intermediate Similarity | NPD6569 | Phase 2 |
0.8255 | Intermediate Similarity | NPD6494 | Phase 2 |
0.825 | Intermediate Similarity | NPD5658 | Approved |
0.8191 | Intermediate Similarity | NPD7414 | Clinical (unspecified phase) |
0.8177 | Intermediate Similarity | NPD7069 | Discontinued |
0.8164 | Intermediate Similarity | NPD5070 | Clinical (unspecified phase) |
0.8069 | Intermediate Similarity | NPD5863 | Clinical (unspecified phase) |
0.8063 | Intermediate Similarity | NPD4889 | Approved |
0.8021 | Intermediate Similarity | NPD1923 | Clinical (unspecified phase) |
0.8018 | Intermediate Similarity | NPD7729 | Clinical (unspecified phase) |
0.7921 | Intermediate Similarity | NPD4039 | Approved |
0.7921 | Intermediate Similarity | NPD4033 | Approved |
0.7921 | Intermediate Similarity | NPD4035 | Approved |
0.7921 | Intermediate Similarity | NPD4795 | Phase 2 |
0.7921 | Intermediate Similarity | NPD4036 | Approved |
0.7921 | Intermediate Similarity | NPD4122 | Approved |
0.7921 | Intermediate Similarity | NPD4037 | Approved |
0.7921 | Intermediate Similarity | NPD4038 | Approved |
0.7921 | Intermediate Similarity | NPD31 | Approved |
0.7921 | Intermediate Similarity | NPD4034 | Approved |
0.7921 | Intermediate Similarity | NPD32 | Approved |
0.7919 | Intermediate Similarity | NPD6861 | Clinical (unspecified phase) |
0.7919 | Intermediate Similarity | NPD4418 | Discontinued |
0.791 | Intermediate Similarity | NPD6477 | Clinical (unspecified phase) |
0.79 | Intermediate Similarity | NPD6219 | Discontinued |
0.7887 | Intermediate Similarity | NPD7674 | Phase 3 |
0.7887 | Intermediate Similarity | NPD7675 | Phase 3 |
0.7887 | Intermediate Similarity | NPD7676 | Clinical (unspecified phase) |
0.7882 | Intermediate Similarity | NPD5530 | Phase 1 |
0.788 | Intermediate Similarity | NPD6963 | Approved |
0.788 | Intermediate Similarity | NPD6964 | Approved |
0.7879 | Intermediate Similarity | NPD3477 | Phase 2 |
0.7879 | Intermediate Similarity | NPD3478 | Clinical (unspecified phase) |
0.7843 | Intermediate Similarity | NPD7222 | Phase 2 |
0.7812 | Intermediate Similarity | NPD3386 | Phase 2 |
0.7811 | Intermediate Similarity | NPD4396 | Clinical (unspecified phase) |
0.7807 | Intermediate Similarity | NPD8091 | Phase 3 |
0.7807 | Intermediate Similarity | NPD6872 | Clinical (unspecified phase) |
0.7778 | Intermediate Similarity | NPD4551 | Phase 2 |
0.7753 | Intermediate Similarity | NPD4926 | Clinical (unspecified phase) |
0.7736 | Intermediate Similarity | NPD5930 | Phase 3 |
0.7723 | Intermediate Similarity | NPD1739 | Approved |
0.7723 | Intermediate Similarity | NPD1740 | Approved |
0.7721 | Intermediate Similarity | NPD7426 | Phase 1 |
0.7701 | Intermediate Similarity | NPD2780 | Approved |
0.7701 | Intermediate Similarity | NPD2782 | Approved |
0.7688 | Intermediate Similarity | NPD1304 | Clinical (unspecified phase) |
0.7688 | Intermediate Similarity | NPD1038 | Approved |
0.7671 | Intermediate Similarity | NPD7558 | Phase 2 |
0.7667 | Intermediate Similarity | NPD6140 | Clinical (unspecified phase) |
0.7659 | Intermediate Similarity | NPD3397 | Phase 2 |
0.7653 | Intermediate Similarity | NPD4375 | Approved |
0.7644 | Intermediate Similarity | NPD5602 | Clinical (unspecified phase) |
0.7642 | Intermediate Similarity | NPD6568 | Discontinued |
0.7638 | Intermediate Similarity | NPD4372 | Phase 1 |
0.7632 | Intermediate Similarity | NPD7859 | Phase 2 |
0.763 | Intermediate Similarity | NPD5612 | Discontinued |
0.7626 | Intermediate Similarity | NPD4885 | Approved |
0.7619 | Intermediate Similarity | NPD2781 | Approved |
0.7608 | Intermediate Similarity | NPD4131 | Phase 3 |
0.7594 | Intermediate Similarity | NPD7823 | Clinical (unspecified phase) |
0.7589 | Intermediate Similarity | NPD4875 | Phase 3 |
0.7589 | Intermediate Similarity | NPD4876 | Phase 3 |
0.7588 | Intermediate Similarity | NPD2334 | Discontinued |
0.7585 | Intermediate Similarity | NPD7452 | Approved |
0.7585 | Intermediate Similarity | NPD7453 | Approved |
0.7583 | Intermediate Similarity | NPD5903 | Approved |
0.7583 | Intermediate Similarity | NPD5902 | Approved |
0.7565 | Intermediate Similarity | NPD5751 | Clinical (unspecified phase) |
0.7548 | Intermediate Similarity | NPD2739 | Clinical (unspecified phase) |
0.7536 | Intermediate Similarity | NPD7571 | Clinical (unspecified phase) |
0.7527 | Intermediate Similarity | NPD4584 | Approved |
0.7512 | Intermediate Similarity | NPD7719 | Discontinued |
0.75 | Intermediate Similarity | NPD1954 | Phase 1 |
0.75 | Intermediate Similarity | NPD4118 | Clinical (unspecified phase) |
0.7455 | Intermediate Similarity | NPD8052 | Clinical (unspecified phase) |
0.7452 | Intermediate Similarity | NPD5601 | Phase 2 |
0.7449 | Intermediate Similarity | NPD4203 | Approved |
0.7449 | Intermediate Similarity | NPD4204 | Approved |
0.7448 | Intermediate Similarity | NPD1078 | Clinical (unspecified phase) |
0.7443 | Intermediate Similarity | NPD6553 | Clinical (unspecified phase) |
0.7442 | Intermediate Similarity | NPD6500 | Approved |
0.7442 | Intermediate Similarity | NPD6501 | Approved |
0.7441 | Intermediate Similarity | NPD4502 | Phase 2 |
0.7437 | Intermediate Similarity | NPD1034 | Phase 3 |
0.7437 | Intermediate Similarity | NPD1033 | Clinical (unspecified phase) |
0.7424 | Intermediate Similarity | NPD7424 | Clinical (unspecified phase) |
0.7424 | Intermediate Similarity | NPD6344 | Clinical (unspecified phase) |
0.7421 | Intermediate Similarity | NPD4995 | Approved |
0.7421 | Intermediate Similarity | NPD4996 | Approved |
0.7419 | Intermediate Similarity | NPD1856 | Discontinued |
0.7416 | Intermediate Similarity | NPD1392 | Approved |
0.7415 | Intermediate Similarity | NPD3825 | Phase 3 |
0.7409 | Intermediate Similarity | NPD7555 | Discontinued |
0.7401 | Intermediate Similarity | NPD7620 | Phase 2 |
0.7396 | Intermediate Similarity | NPD4724 | Clinical (unspecified phase) |
0.7389 | Intermediate Similarity | NPD3396 | Approved |
0.7389 | Intermediate Similarity | NPD6790 | Phase 1 |
0.7389 | Intermediate Similarity | NPD3395 | Approved |
0.7387 | Intermediate Similarity | NPD4920 | Clinical (unspecified phase) |
0.7387 | Intermediate Similarity | NPD2917 | Approved |
0.7387 | Intermediate Similarity | NPD4919 | Phase 3 |
0.7387 | Intermediate Similarity | NPD4921 | Phase 3 |
0.7385 | Intermediate Similarity | NPD1032 | Phase 2 |
0.7381 | Intermediate Similarity | NPD5529 | Phase 1 |
0.7381 | Intermediate Similarity | NPD5528 | Clinical (unspecified phase) |
0.7376 | Intermediate Similarity | NPD4925 | Approved |
0.7374 | Intermediate Similarity | NPD5083 | Clinical (unspecified phase) |
0.7373 | Intermediate Similarity | NPD5147 | Discontinued |
0.7371 | Intermediate Similarity | NPD5944 | Phase 1 |
0.7371 | Intermediate Similarity | NPD5945 | Phase 1 |
0.7368 | Intermediate Similarity | NPD2060 | Approved |
0.7368 | Intermediate Similarity | NPD3003 | Approved |
0.7358 | Intermediate Similarity | NPD5067 | Phase 2 |
0.7358 | Intermediate Similarity | NPD5066 | Phase 2 |
0.7353 | Intermediate Similarity | NPD2482 | Clinical (unspecified phase) |
0.735 | Intermediate Similarity | NPD7169 | Suspended |
0.7347 | Intermediate Similarity | NPD1620 | Clinical (unspecified phase) |
0.734 | Intermediate Similarity | NPD6361 | Phase 2 |
0.733 | Intermediate Similarity | NPD3541 | Clinical (unspecified phase) |
0.733 | Intermediate Similarity | NPD3837 | Clinical (unspecified phase) |
0.7327 | Intermediate Similarity | NPD6242 | Discontinued |
0.7323 | Intermediate Similarity | NPD5522 | Clinical (unspecified phase) |
0.7317 | Intermediate Similarity | NPD2952 | Discontinued |
0.7316 | Intermediate Similarity | NPD6525 | Clinical (unspecified phase) |
0.7315 | Intermediate Similarity | NPD3354 | Phase 2 |
0.731 | Intermediate Similarity | NPD2600 | Approved |
0.731 | Intermediate Similarity | NPD2601 | Approved |
0.731 | Intermediate Similarity | NPD2599 | Approved |
0.7299 | Intermediate Similarity | NPD7672 | Approved |
0.7299 | Intermediate Similarity | NPD7671 | Approved |
0.7297 | Intermediate Similarity | NPD7567 | Approved |
0.7297 | Intermediate Similarity | NPD1900 | Clinical (unspecified phase) |
0.7296 | Intermediate Similarity | NPD4072 | Approved |
0.7296 | Intermediate Similarity | NPD4071 | Approved |
0.7277 | Intermediate Similarity | NPD6281 | Approved |
0.7277 | Intermediate Similarity | NPD8063 | Discontinued |
0.7273 | Intermediate Similarity | NPD5007 | Approved |
0.7273 | Intermediate Similarity | NPD6991 | Approved |
0.7269 | Intermediate Similarity | NPD7025 | Clinical (unspecified phase) |
0.7269 | Intermediate Similarity | NPD5905 | Phase 1 |
0.7264 | Intermediate Similarity | NPD4437 | Phase 3 |
0.7263 | Intermediate Similarity | NPD9705 | Discontinued |
0.7263 | Intermediate Similarity | NPD112 | Approved |
0.7261 | Intermediate Similarity | NPD8100 | Phase 3 |
0.7255 | Intermediate Similarity | NPD5575 | Clinical (unspecified phase) |
0.7255 | Intermediate Similarity | NPD802 | Phase 2 |
0.7249 | Intermediate Similarity | NPD2581 | Approved |
0.7249 | Intermediate Similarity | NPD2582 | Approved |
0.7246 | Intermediate Similarity | NPD7956 | Approved |
0.7246 | Intermediate Similarity | NPD7955 | Approved |
0.7238 | Intermediate Similarity | NPD3946 | Clinical (unspecified phase) |
0.7233 | Intermediate Similarity | NPD6769 | Clinical (unspecified phase) |
0.7228 | Intermediate Similarity | NPD4021 | Phase 2 |
0.7225 | Intermediate Similarity | NPD6975 | Discontinued |
0.722 | Intermediate Similarity | NPD6590 | Discontinued |
0.722 | Intermediate Similarity | NPD1602 | Discontinued |
0.722 | Intermediate Similarity | NPD6491 | Clinical (unspecified phase) |
0.7217 | Intermediate Similarity | NPD2189 | Approved |
0.7217 | Intermediate Similarity | NPD2187 | Approved |
0.721 | Intermediate Similarity | NPD5008 | Approved |
0.7205 | Intermediate Similarity | NPD5051 | Phase 1 |
0.7202 | Intermediate Similarity | NPD7194 | Discontinued |
0.7198 | Intermediate Similarity | NPD4664 | Clinical (unspecified phase) |
0.7193 | Intermediate Similarity | NPD7885 | Phase 2 |
0.7193 | Intermediate Similarity | NPD7886 | Phase 2 |
0.719 | Intermediate Similarity | NPD4044 | Discontinued |
0.7184 | Intermediate Similarity | NPD6550 | Discontinued |
0.7179 | Intermediate Similarity | NPD4083 | Discontinued |
0.7175 | Intermediate Similarity | NPD5559 | Phase 2 |
0.7175 | Intermediate Similarity | NPD7710 | Clinical (unspecified phase) |
0.717 | Intermediate Similarity | NPD5429 | Discontinued |
0.7169 | Intermediate Similarity | NPD8479 | Phase 2 |
0.7168 | Intermediate Similarity | NPD2757 | Phase 2 |
0.7167 | Intermediate Similarity | NPD8101 | Phase 3 |
0.7167 | Intermediate Similarity | NPD6244 | Phase 3 |
0.7167 | Intermediate Similarity | NPD6243 | Phase 3 |
0.7163 | Intermediate Similarity | NPD5999 | Phase 2 |
0.7163 | Intermediate Similarity | NPD4548 | Discontinued |
0.7157 | Intermediate Similarity | NPD5100 | Phase 3 |
0.7156 | Intermediate Similarity | NPD4429 | Discontinued |
0.715 | Intermediate Similarity | NPD6262 | Clinical (unspecified phase) |
0.715 | Intermediate Similarity | NPD7948 | Phase 1 |
0.715 | Intermediate Similarity | NPD1622 | Discontinued |
0.7149 | Intermediate Similarity | NPD5539 | Phase 2 |
0.7143 | Intermediate Similarity | NPD5669 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD5801 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD7112 | Discontinued |
0.7137 | Intermediate Similarity | NPD6503 | Clinical (unspecified phase) |
0.7136 | Intermediate Similarity | NPD3324 | Clinical (unspecified phase) |
PubChem CID   | 73442 |
ChEMBL   | CHEMBL274189 |
ZINC   |
Molecular Weight:   | 352.15 |
ALogP:   | -1.3839 |
MLogP:   | 3.22 |
XLogP:   | 2.969 |
# Rotatable Bonds:   | 8 |
Polar Surface Area:   | 40.8 |
# H-Bond Aceptor:   | 0 |
# H-Bond Donor:   | 0 |
# Rings:   | 4 |
# Heavy Atoms:   | 26 |